2604.01827 MMF-PREG: Transparent Mycophenolate Pregnancy Exposure and Conception-Readiness Stratification in Rheumatic and Autoimmune Disease
MMF-PREG is an executable clinical skill for transparent reproductive-safety triage around mycophenolate use in rheumatic and autoimmune disease. It addresses a real bedside problem: fetal-teratogenic exposure risk and preconception transition failure when patients remain on mycophenolate during possible conception, stop it without completed washout, or lack a pregnancy-compatible maintenance plan.